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Michael-Wadih Sourial1, Robert Sabbagh1, Alexandre Doueik2 and Yves Ponsot1*Abstract
We herein report the case of a right-sided testicular fibrothecoma in a 17 year old male and review the pertinent
literature relatable to this rare, benign lesion.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/7738283021019280.
Keywords: Fibrothecoma, Sex cord stromal tumorsBackground
Sex cord/stromal tumors (SCSTs) are rare, comprising ap-
proximately 4–5% of all gonadal neoplasms that originate
from the gonadal matrix. The term refers to neoplasms
containing Leydig cells, Sertoli cells, granulosa cells, or
theca cells [1]. In females, thecomas are tumors that arise
from the hormone-secreting theca cells that surround the
ovarian follicles. They are relatively common SCSTs, typ-
ically presenting in post-menopausal women in their mid-
60s. They are some of the most hormonally active tumors
of all SCSTs and usually present with signs or symptoms
of excess estrogen such as abnormal vaginal bleeding,
endometrial hyperplasia or adenocarcinoma [2]. Bilateral
or extragonadal disease is extremely rare. These tumors
are clinically benign and their surgical resection is cura-
tive. In males however, only a few case reports of theca
cell tumors have been reported, and only one case report
of a pure fibrothecoma has been reported. We report what
to our knowledge is the second case of pure fibrothecoma.Case presentation
A seventeen year old otherwise healthy male was referred
to us for a palpable, painless right-sided testicular mass. He
had a normal physical appearance with no apparent
dysmorphisms or signs of feminization, and was evaluated
a Tanner stage V. Testicular ultrasound showed a* Correspondence: yves.ponsot@usherbrooke.ca
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reproduction in any medium, provided the orhypoechogenic solitary 8 mm solid right intratesticular
mass of undetermined etiology with no associated hydro-
cele. The left testicle was normal. Pre-operative testicular
markers were negative as follows: ß-HCG< 1 (normal 0–5
mIU/mL), AFP 1.2 (normal < 7 ng/mL), and LDH 179 (nor-
mal 120–250 IU/L). Sex hormones were not obtained. We
carried out a right radical inguinal orchiectomy on the sus-
picion of a malignant tumor and the patient was discharged
the same day with no early or late complications. Post-
operative computed tomography (CT) scans of the thorax,
abdomen and pelvis showed absence of retroperitoneal
adenopathies or any suspicious metastatic lesions. Final
pathology report described a 9 × 9 × 9 mm whitish-beige
mass that was well-circumscribed and non-adherent to the
adjacent testicular parenchyma (Figure 1). There was no
lympho-vascular invasion, invasion of the tunica albuginae,
invasion of the rete testis or epididymis, or any other tes-
ticular lesions. The morphologic appearance and immuno-
histochemical profile suggested a testicular fibrothecoma
(Figure 2). Margins were negative.
Discussion
Sex cord/stromal tumors are rare, comprising only 4–5%
of all gonadal neoplasms. By definition, the term SCSTs
refers to neoplasms containing Leydig cells, Sertoli cells,
granulosa cells, or theca cells. The scarcity of these tumors
limits our understanding of their natural history, treat-
ment, and prognosis. The clinical and scientific signifi-
cance of this case presentation is to increase awareness of
the occurrence of this rare entity, especially to practicing
urologists and pathologists, and also to review its clinicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Fibrothecoma, note the well-circumscribed lesion,
non-adherent to adjacent testicular parenchyma.
Figure 3 Fibrothecoma, smooth muscle actin stain.
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nosis for a testicular tumor.
In females, fibrothecomas typically present in post-
menopausal women in their mid-60s, and very rarely
present in women less than 30 years of age [3]. In males,
only four case reports of testicular fibrothecoma have
been reported. Van der Horst et al. [4] reported the first
and only case of a pure fibrothecoma in a 54 year old male
presenting with intermittent pain in his left testis.
Clinical presentation of this rare entity will depend on
the age and sex of the patient. Theca cells are stimulated
by luteinizing hormone (LH) and secrete androstenedione,
which is uptaken by the adjacent granulosa cells and
converted into estradiol. In females, excess estrogen may
lead to abnormal vaginal bleeding, endometrial hyperpla-
sia or endometrial adenocarcinoma [2]. Occasionally the
thecomas are luteinized and may secrete androgens and
even potentially induce masculinization. In children, they
can present as precocious sexual puberty evidenced byFigure 2 Fibrothecoma, H&E stain.prominent external genitalia, pubic hair growth or mascu-
line voice. Males with these tumors may present with
signs and symptoms of estrogen or androgen excess, in-
cluding gynecomastia, impotence or decreased libido. The
most common presentation in males remains a painless
testicular mass.
Typical cell type findings include spindle-shaped
cells without any formally identifiable Sertoli, Leydig,
or granulosa cell component. Fibrothecoma tumors are
usually well delineated, highly cellular, monotonous,
and without any cytological atypia. Sometimes these
tumors contain acellular fibrohyalinized zones. Mitotic
activity is typically reduced. Immunohistochemistry
analysis will show that the spindle-shaped cells express
positivity for smooth muscle cells marker, smooth
muscle actin (Figure 3), CD99, PS100, inhibin (Figure 4),
and keratins.
It has been postulated that ovarian fibrothecomas are
etiologically associated with a tumorigenic syndrome
called nevoid basal-cell carcinoma syndrome, also knownFigure 4 Fibrothecoma, inhibin stain.
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PTCH. Gorlin syndrome is an autosomal dominant syn-
drome that presents with neurological and musculo-skeletal
anomalies, unusual facial appearance, and a higher risk of
basal cell carcinoma at or around puberty. Ueda et al. [5]
have reported the first case of a testicular thecoma in an
11 year old boy with Gorlin syndrome.
Schenkman et al. [6] reported a case of synchronous bi-
lateral testicular tumors of different histological types, with
simultaneous appearance of a mixed non-seminomatous
germ cell tumor of the left testis and theca cell tumor of
the right testis in a 34 year old male. Eble et al. [7] reported
the only known case to date of a metastatic SCST of the
testis. The primary lesion was mixed and consisted of
granulosa cells, theca cells, Sertoli cells and undifferentiated
gonadal stroma. Metastasis occurred in the retroperitoneal
lymph nodes and was confirmed by biopsy which showed a
Sertoli cell predominance. The patient died 13 months after
orchiectomy.
Diagnostic evaluation includes laboratory testing and
imaging. Elevated levels of testosterone or estrogen may
be seen in secreting tumors, but these are typically not
obtained pre-operatively because the diagnosis of SCST is
not suspected [3]. The common testicular tumor markers
LDH, AFP and hCG are typically normal in SCSTs. Im-
aging in any male presenting with a testicular mass, or un-
explained testicular signs or symptoms should always
include testicular ultrasonography.
In the majority of cases, surgical resection of SCSTs
is the primary treatment and is most often curative.
Fibrothecomas are clinically benign and are usually con-
fined to the gonads at the time of clinical presentation.
With early-stage detection and complete excision of the
lesion, the overall prognosis is excellent.
Conclusion
We present what to our knowledge is the second case of a
pure fibrothecoma in a male. Fibrothecomas are a distinct
clinical and pathologic entity among sex cord/stromal tu-
mors, and awareness of this rare entity is especially im-
portant for practicing pathologists and urologists.
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